Our study presented one such case (patient #20) whose AITL developed after 10 years of PV and the two hematologic neoplasms shared three identical JAK2 and TET2 mutations (Figure 3B). The gene discussed is TET2; the disease is hematopoietic and lymphoid system neoplasm.